Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases successfully treated with CIP,% cases successfully treated with TET,% cases successfully treated with CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"22,335 (8,213, 34,154)","60.3% (46.4%, 88.8%)","0.0% (0.0%, 0.0%)","0.0% (0.0%, 0.0%)","60.3% (46.4%, 88.8%)","21.1 (16.3, 31.1)","0.0 (0.0, 0.0)","0.0 (0.0, 0.0)","21.1 (16.3, 31.1)",,,,,
"(p=None, None), q=(None, None), c=0.500)","19,498 (7,459, 31,451)","68.9% (52.7%, 96.2%)","20.6% (12.7%, 31.6%)","2.0% (1.3%, 2.9%)","46.2% (35.0%, 68.0%)","24.1 (18.4, 33.7)","7.2 (4.4, 11.1)","0.7 (0.4, 1.0)","16.2 (12.2, 23.8)","-13.4% (-26.1%, -1.4%)","14.5% (5.5%, 23.3%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-23.1% (-32.4%, -13.8%)"
"(p=None, None), q=(None, None), c=0.750)","19,760 (8,166, 32,861)","68.7% (52.0%, 94.7%)","30.2% (18.9%, 44.5%)","2.9% (1.7%, 4.0%)","35.7% (24.1%, 55.6%)","24.1 (18.2, 33.1)","10.6 (6.6, 15.6)","1.0 (0.6, 1.4)","12.5 (8.4, 19.5)","-11.6% (-23.4%, 0.4%)","14.3% (4.7%, 22.1%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-40.5% (-57.5%, -29.1%)"
"(p=None, None), q=(None, None), c=1.000)","19,755 (8,199, 31,726)","69.6% (53.5%, 96.5%)","40.2% (24.5%, 61.4%)","3.7% (2.2%, 5.2%)","25.7% (12.8%, 44.4%)","24.4 (18.7, 33.8)","14.1 (8.6, 21.5)","1.3 (0.8, 1.8)","9.0 (4.5, 15.5)","-11.3% (-25.9%, 4.2%)","15.8% (7.3%, 24.6%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-57.0% (-78.2%, -42.0%)"
